Regulatory Considerations on the use of Machine Learning based tools in Clinical Trials

BACKGROUND: The widespread increasing use of machine learning (ML) based tools in clinical trials (CTs) impacts the activities of Regulatory Agencies (RAs) that evaluate the development of investigational medicinal products (IMPs) in clinical studies to be carried out through the use of data-driven...

Descripción completa

Detalles Bibliográficos
Autores principales: Massella, Maurizio, Dri, Diego Alejandro, Gramaglia, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638313/
https://www.ncbi.nlm.nih.gov/pubmed/36373014
http://dx.doi.org/10.1007/s12553-022-00708-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638313/
https://www.ncbi.nlm.nih.gov/pubmed/36373014
http://dx.doi.org/10.1007/s12553-022-00708-0

Ejemplares similares